Although the sample size was very small (n = 3), these data raise the possibility that ADAM12 is hypomethylated, relative to that of healthy women, not only in the tumour tissue, but also in the cfDNA released into the plasma from TNBC patients. Here, ADAM12 is linked to neoplasm.